Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...

BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe ...

Swiss entrepreneur Willy Michel, who founded Ypsomed, controls TecMed. His son, Simon Michel, is CEO of Ypsomed. Included in ...

Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK.

Boston Scientific won FDA approval for Agent last year, making it the first drug-coated coronary balloon available in the U.S. The company also offers it commercially in several international markets, ...

Abbott, Dexcom, Medtronic, Roche and Insulet represent the top five largest diabetes tech companies in the world. [Images from the companies] What has changed in the last year as diabetes technology ...

Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast.

Sayer originally joined Dexcom’s board in November 2007, then became president in 2011. He held the role of COO, like Leach, until his promotion to CEO in 2015.